SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001123292-19-001061
Filing Date
2019-08-15
Accepted
2019-08-15 17:24:13
Documents
1
Group Members
MSD CREDIT OPPORTUNITY MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 msdpartnersvaccinex13g.htm SC 13G/A 246235
  Complete submission text file 0001123292-19-001061.txt   247938
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Subject) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90610 | Film No.: 191031110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 645 FIFTH AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE 21ST FLOOR NEW YORK NY 10022 (212) 303-1650
MSD Partners, L.P. (Filed by) CIK: 0001514334 (see all company filings)

IRS No.: 271522220 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A